newsfilter
← Latest News
GlobeNewswire·

Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update

Monotherapy activity of long duration in patients who have progressed on checkpoint therapy via a novel immuno-oncology mechanism of action with PD-L1 ETB (MT-6402) programEarly indication of monotherapy activity in